企業プロフィール

Vaxxinity 株価・ニュース・カタリスト

ティッカー:
VAXX
取引所:
NASDAQ
セクター:
Biopharma
所在地:
United States

株価パフォーマンス

0.00 USD (-99.61%)

終値

最終更新: 2026年8月17日

時価総額

株価変動の要因

As of Aug 17, 2026, VAXX closed down 99.6% at $0.0001. No new same-company headline was identified in the current news window.

企業概要

事業概要

Vaxxinity was a vaccine and immunotherapy company focused on synthetic vaccine development before its business was wound down and restructured. Its story reflected the challenge of translating platform ambition into commercial value.

所在地とセクター分類

Headquartered in the United States and listed on NASDAQ before restructuring, Vaxxinity sat in vaccine biotechnology.

ビジネスモデルの特徴

The business depended on platform validation, clinical progress, and investor patience for a long-duration vaccine story.

バイオ業界での位置付け

Vaxxinity is best treated as a historical vaccine-platform case rather than a live catalyst leader.

今後のカタリスト

  • Vaxxinity’s catalysts are its vaccine platform and any strategic update that clarifies the company’s next direction. The stock needs a clearer answer on how the platform becomes value-generating.

最近のニュース

    類似銘柄

    事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。